Gene therapies must become miracles of medicine : vimarsana.

Otherwise they might end up a niche treatment for a small number of patients in rich countries | Briefing

Related Keywords

Switzerland , Japan , Germany , Berkeley , California , United States , Netherlands , United Kingdom , To Stat , Midi Pyrées , France , Massachusetts , Boston , Cambridge , Cambridgeshire , San Francisco , Britain , America , French , Japanese , American , Dutch , Swiss , Jay Bradner , Nicole Paulk , Janet Lambert , Fyodor Urnov , Oxford Astrazeneca , Bernhardt Zeiher , David Lillicrap , Mike Mccune , Ethan Ralston , Karen Pignet Aiach , James Wilson , Jesse Gelsinger , University Of California , Amicus Therapeutics , Queen University , Centre For Biomedical Innovation In Cambridge , Melinda Gates Foundation , Novartis , Pfizer , Vertex Pharmaceuticals , Aspen Institute , Novartis Institutes For Biomedical Research , Blue Cross Shield Association , Drug Administration , Boston Consulting Group , University Of Pennsylvania , European Medicines Agency , Alliance For Regenerative Medicine , Leber Hereditary Optic Neuropathy , Regenerative Medicine , Biomedical Innovation , Solid Biosciences , August Novartis , Novartis Institutes , Global Blood Therapies ,